Insider · CIK 0001904156
Michelle McMurry-Heath
Files at RVTY (REVVITY, INC.), BVS (Bioventus Inc.). First filing May 30, 2025, latest Mar 13, 2026.
Michelle McMurry-Heath files SEC Form 4 as director at RVTY (REVVITY, INC.), and also at BVS (Bioventus Inc.). Since May 30, 2025, Michelle McMurry-Heath has reported 0 open-market buys worth $0 and 4 open-market sells worth $350k, the latest filed on Mar 13, 2026.
A track record needs three past buys with six months of prices behind them; Michelle McMurry-Heath has 0, so none is measured yet.
The newest scored trade: sold $105k of BVS on Mar 11, 2026, filed Mar 13, 2026, scored 30 (weak). In the last 12 months: 0 buys worth $0 and 3 sells worth $295k.
Where the trades landed
Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.
BVS: Bioventus Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
RVTY: REVVITY, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | BVSsell Bioventus Inc. | $105k 12,000 shares | -21% | +45% from low-18% from high | |
| 35Weak | REVVITY, INC. | $58k 600 shares | -12% | +18% from low-18% from high | |
| 31Weak | BVSsell Bioventus Inc. | $131k 17,701 shares | -24% | +21% from low-40% from high | |
| 27Weak | RVTYsell REVVITY, INC. | $55k 600 shares | -11% | +3% from low-28% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Mar 11, 2026 | BVS Bioventus Inc. | 12,000 0.02% of outstanding | $106k | Mar 11, 2026 | none |
| Feb 23, 2026 | RVTY REVVITY, INC. | 600 0.00% of outstanding | $58k | Feb 23, 2026 | none |
| Nov 7, 2025 | BVS Bioventus Inc. | 27,000 0.04% of outstanding | $200k | Nov 7, 2025 | none |
| May 29, 2025 | RVTY REVVITY, INC. | 600 0.00% of outstanding | $55k | May 29, 2025 | none |
| Feb 6, 2025 | RVTY REVVITY, INC. | 1,970 0.00% of outstanding | $235k | Feb 6, 2025 | none |
Transactions
Every row this insider has filed, 14 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 2, 2026 | BVS Bioventus Inc. | MOption exercise Class A Common Stock | +32,282 | $0.00 | $0 | 77,279 | Jun 4, 2026 |
| Jun 2, 2026 | BVS Bioventus Inc. | MOption exercise Restricted Stock Unitsderivative | -32,282 | $0.00 | $0 | 0 | Jun 4, 2026 |
| Jun 3, 2026 | BVS Bioventus Inc. | AGrant or award Restricted Stock Unitsderivative | +25,146 | $0.00 | $0 | 25,146 | Jun 4, 2026 |
| May 7, 2026 | RVTY REVVITY, INC. | AGrant or award Common Stock | +1,015 | $0.00 | $0 | 5,248 | May 11, 2026 |
| May 7, 2026 | RVTY REVVITY, INC. | AGrant or award Common Stock | +1,265 | $0.00 | $0 | 6,513 | May 11, 2026 |
| Mar 11, 2026 | BVS Bioventus Inc. | SOpen-market sale Class A Common Stock | -12,000 | $8.79 | $105k | 44,997 | Mar 13, 2026 |
| Feb 23, 2026 | RVTY REVVITY, INC. | SOpen-market sale Common Stock | -600 | $97.26 | $58k | 4,233 | Feb 25, 2026 |
| Nov 7, 2025 | BVS Bioventus Inc. | SOpen-market sale Class A Common Stock | -17,701 | $7.42 | $131k | 56,997 | Nov 10, 2025 |
| Jun 2, 2025 | BVS Bioventus Inc. | MOption exercise Class A Common Stock | +26,493 | $0.00 | $0 | 74,698 | Jun 4, 2025 |
| Jun 2, 2025 | BVS Bioventus Inc. | MOption exercise Restricted Stock Unitsderivative | -26,493 | $0.00 | $0 | 0 | Jun 4, 2025 |
| Jun 3, 2025 | BVS Bioventus Inc. | AGrant or award Restricted Stock Unitsderivative | +32,282 | $0.00 | $0 | 32,282 | Jun 4, 2025 |
| May 29, 2025 | RVTY REVVITY, INC. | SOpen-market sale Common Stock | -600 | $92.17 | $55k | 4,833 | May 30, 2025 |
| Apr 30, 2025 | RVTY REVVITY, INC. | AGrant or award Common Stock | +1,074 | $0.00 | $0 | 4,095 | May 1, 2025 |
| Apr 30, 2025 | RVTY REVVITY, INC. | AGrant or award Common Stock | +1,338 | $0.00 | $0 | 5,433 | May 1, 2025 |
Questions about Michelle McMurry-Heath
Answered from the filings on this page, as of the latest one.
Is Michelle McMurry-Heath buying or selling?
In the last 12 months Michelle McMurry-Heath reported 0 open-market buys worth $0 and 3 open-market sells worth $295k on SEC Form 4; the latest was sold $105k of BVS on Mar 11, 2026. Grants, option exercises and tax withholding are not counted.
How did Michelle McMurry-Heath's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Michelle McMurry-Heath has 0.
Where does Michelle McMurry-Heath file Form 4?
Michelle McMurry-Heath has filed Form 4 at RVTY (REVVITY, INC.); BVS (Bioventus Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.